Founder Profile: From Startup Failures to Biohacking

Marciano's entrepreneurial journey began at age 13, developing websites for local businesses in Sorocaba, Brazil. Before his current role, he founded ACCESS Security Lab, a cybersecurity firm, and Sudobank, a digital bank that was an early adopter of the open banking concept in Brazil. He has also co-authored a book on the role of artificial intelligence in business scalability. His current venture in the longevity space is a U.S.-based healthtech company called Livvay, which focuses on integrative health. This aligns with a growing market, with the anti-aging and longevity industry projected to reach a market value of $64 billion by 2026. Major players in this space include Altos Labs, backed by Jeff Bezos with $3 billion in funding, and Juvenescence, which has raised over $200 million to develop products that modify aging. For consumer health startups, building trust is paramount and can be achieved through transparency with evidence-backed claims and fostering a sense of community. Successful apps often employ AI and machine learning to deliver personalized health plans, analyzing data from sources like electronic health records and wearables to predict health outcomes and tailor recommendations. This data-driven personalization can lead to higher user engagement and retention. Integrating with wearables like Apple HealthKit, Fitbit, and Oura is a key strategy for enhancing personalization, though it presents development challenges. While native APIs exist for each ecosystem, unified APIs can significantly cut down development time from months to weeks by normalizing data from various devices. However, developers must navigate privacy-first features like Apple's HealthKit, which stores data locally and requires a native iOS app for data syncing. Navigating health data privacy is a major consideration, as consumer health apps often fall outside the direct jurisdiction of HIPAA. The FTC's Health Breach Notification Rule requires apps not covered by HIPAA to inform users of data breaches. Additionally, a patchwork of state laws, like California's CPRA and Washington's My Health My Data Act, are creating stricter regulations around the collection and use of sensitive health information. The transition from a solo technical founder to a CEO involves a significant mindset shift from being a "doer" to a "leader." This often means moving from a specialist to a generalist, focusing more on strategy and enabling the team rather than hands-on execution. Founder communities and mentorship can be critical in navigating this often-isolating journey, which many investors view as high-risk for solo founders. Biohacking, the practice of making incremental changes to one's health and biology, ranges from data-driven wellness to more experimental approaches. Common practices include optimizing sleep, intermittent fasting to promote cellular autophagy, and using cold exposure to reduce inflammation. The goal is often to extend "healthspan"—the years lived in good health—a concept central to the longevity medicine field. Early-stage fundraising in digital health requires a compelling narrative that clearly articulates the problem, the uniqueness of the solution, and its potential market impact. Investors in this space, such as Healthy Ventures and Flare Capital, often look for a clear path to commercialization and reimbursement. AI-focused digital health startups have recently attracted the majority of investment, with significantly larger deal sizes compared to non-AI companies.